- Home
- AVIR vs MXF Comparison
AVIR vs MXF Comparison
Compare AVIR & MXF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- MXF
- Stock Information
- Founded
- AVIR 2012
- MXF 1981
- Country
- AVIR United States
- MXF Mexico
- Employees
- AVIR N/A
- MXF N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- MXF Trusts Except Educational Religious and Charitable
- Sector
- AVIR Health Care
- MXF Finance
- Exchange
- AVIR Nasdaq
- MXF Nasdaq
- Market Cap
- AVIR 273.7M
- MXF 239.1M
- IPO Year
- AVIR 2020
- MXF N/A
- Fundamental
- Price
- AVIR $2.97
- MXF $16.65
- Analyst Decision
- AVIR Hold
- MXF
- Analyst Count
- AVIR 1
- MXF 0
- Target Price
- AVIR $6.00
- MXF N/A
- AVG Volume (30 Days)
- AVIR 441.1K
- MXF 27.4K
- Earning Date
- AVIR 05-12-2025
- MXF 01-01-0001
- Dividend Yield
- AVIR N/A
- MXF 4.70%
- EPS Growth
- AVIR N/A
- MXF N/A
- EPS
- AVIR N/A
- MXF N/A
- Revenue
- AVIR N/A
- MXF N/A
- Revenue This Year
- AVIR N/A
- MXF N/A
- Revenue Next Year
- AVIR N/A
- MXF N/A
- P/E Ratio
- AVIR N/A
- MXF N/A
- Revenue Growth
- AVIR N/A
- MXF N/A
- 52 Week Low
- AVIR $2.46
- MXF $14.77
- 52 Week High
- AVIR $4.15
- MXF $19.49
- Technical
- Relative Strength Index (RSI)
- AVIR 56.05
- MXF 65.10
- Support Level
- AVIR $2.78
- MXF $16.58
- Resistance Level
- AVIR $3.03
- MXF $16.35
- Average True Range (ATR)
- AVIR 0.17
- MXF 0.30
- MACD
- AVIR 0.03
- MXF -0.00
- Stochastic Oscillator
- AVIR 88.03
- MXF 75.19
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About MXF Mexico Fund Inc. (The)
Mexico Fund Inc is a United States-based non-diversified, closed-end management investment company. Its investment objective is to seek long-term capital appreciation. The fund seeks to achieve its objective through investment in securities, primary in equity, listed on the Mexican Stock Exchange. The company's portfolio of investments consists of investments in different sectors such as auto parts, airports, building materials, chemical products, consumer products, energy, food, and other sectors. The fund provides a vehicle to investors who wish to invest in Mexican companies through a managed non-diversified portfolio as part of their overall investment program.